skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Zach McLellan, Jack Allen, and guest analyst Cameron Findlater discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including the approval of AndexXa for reversal of Eliquis and Xarelto & Eli Lilly's acquisition of ARMO Biosciences.

Topics covered in this episode include:

  • Analysis of volanesorsen advisory committee meeting - (AKCA IONS) - 0:28
  • Approval of AndexXa for reversal of Eliquis and Xarelto (PTLA BMY PFE BAYR) - 8:13
  • Eli Lilly announces acquisition of ARMO Biosciences (LLY ARMO MRK BMY NKTR) - 17:50

Subscribe to this podcast here